2023

1. In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

   International Journal of Antimicrobial Agents, Vol. 62, Núm. 4

2. Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales

   Antibiotics, Vol. 12, Núm. 6

3. Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections

   The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 5, pp. 1195-1200